Neil M. Cowen, PhD, MBA, President & Chief Scientific Officer

Dr. Cowen has directed the development programs of the company since its founding, most recently as CSO and previously as founding CEO of Essentialis. Prior to Essentialis, Dr. Cowen served as VP Strategic Development of Epicyte Pharmaceutical, a private biotechnology company. Prior to Epicyte, Dr. Cowen functioned in various business development and research management roles in Dow Chemical and a venture backed company acquired by Dow.